SCHEMBL7713338

SCHEMBL7713338

CC1Oc2ccc(C(Cc3ccc(Cl)cc3)NC(=O)OC(C)(C)C)cc2NC1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.42
HSD17B10 Q99714 1/20 0.40
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDR P35968 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
CCKAR P32238 1/20 0.37
CCKBR P32239 1/20 0.37
IDO1 P14902 1/20 0.36
SMYD3 Q9H7B4 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7713294 0.92 PARP1 (0.42) PARP1TP53POLBSMN1; SMN2ALDH1A1
SCHEMBL7713423 0.91 PARP1 (0.41) PARP1HSD17B10TP53POLBSMN1; SMN2
SCHEMBL7708144 0.91 PARP1 (0.42) PARP1HSD17B10TP53ALDH1A1TSHR
SCHEMBL7713374 0.91 PARP1 (0.50) PARP1HSD17B10TP53SMN1; SMN2ALDH1A1
SCHEMBL7711137 0.91 CTSL (0.45) PARP1HSD17B10TP53POLBSMN1; SMN2
SCHEMBL7092472 0.90 HSD17B10 (0.37) PARP1HSD17B10TP53SMN1; SMN2ALDH1A1
SCHEMBL7711371 0.90 PARP1 (0.41) PARP1HSD17B10TP53SMN1; SMN2ALDH1A1
SCHEMBL7708029 0.90 PARP1 (0.41) PARP1HSD17B10TP53SMN1; SMN2ALDH1A1
SCHEMBL7708210 0.89 MC4R (0.41) PARP1HSD17B10TP53POLBSMN1; SMN2
SCHEMBL7708221 0.89 PARP1 (0.40) PARP1HSD17B10TP53SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed